Back to results
US 2025/0025416 A1Published application
A formulation for an effective oral administration of ciclopirox with no adversal gastrointestinal toxicity
AssigneesAtlas Molecular Pharma, S.L., AsociacióN Centro De InvestigacióN Cooperativa En Biociencias-Cic Biogune
InventorsOscar MILLET AGUILAR-GALINDO, Joaquin CASTILLA CASTRILLÒN, Ganeko RERNARDO-SEISDEDOS, Jorge MORENO CHARCO
Life of this patent
Estimating the term…
Abstract
The present invention relates to an oral composition of ciclopirox or a derivate thereof which do not exhibit gastrointestinal toxicity and comprises a therapeutically effective amount of ciclopirox, tocopherol and alginate or their derivates.
Claims20
An oral pharmaceutical composition comprising:
- a therapeutically effective amount of ciclopirox or a pharmaceutically acceptable salt, solvate or prodrug thereof;
- tocopherol or a pharmaceutically acceptable salt, ester or ether thereof;
- and
- alginate or a pharmaceutically acceptable salt, ester or ether thereof.
1 more element
(canceled)
Dependencies are inferred from the claim text.